Tag: Motley Fool

In morning trade, the Vulcan Energy Resources Ltd (ASX: VUL) share price is charging higher.

At the time of writing, the clean lithium company’s shares are up 9% to $6.88.

Why is the Vulcan share price pushing higher?

Investors have responded positively to an announcement this morning which revealed that Vulcan intends to establish a full lithium traceability and CO2 measurement across its supply chain.

According to the release, Vulcan will work with Traceability-as-a-Service company Circulor to achieve this, which it believes is a world-first for the lithium sector.

The company notes that Circulor’s customers include major European automotive manufacturers such as Volvo Cars, Daimler, Polestar and Jaguar Land Rover. It feels this indicates OEMs’ growing need to demonstrate responsible sourcing of raw materials like lithium and to track and manage the embedded CO2 emission in their upstream supply chain for EVs, as they work towards achieving their net zero targets.

In light of this, Vulcan will be implementing Ciculor’s solution to its future lithium supply contracts with European OEMs to help them meet their objectives.

Setting the way forward

Vulcan’s CEO, Dr Francis Wedin, believes this move is setting the way forward for the raw materials industry.

He said: “This collaboration between Circulor and Vulcan will allow us to develop the world’s first fully traceable, transparent and zero carbon lithium product extracted and consumed in Europe. As well as showing Vulcan’s commitment to a transparent supply chain with net zero carbon footprint, it is another industry-leading move by Vulcan that sets the way forward for the raw materials industry to improve and align to OEMs’ goal of producing truly sustainable EVs.”

Circulor’s CEO, Douglas Johnson-Poensgen, added: “The EV battery market in Europe is evolving fast with many new players establishing themselves in the market, and with a clear advantage for those who can prove sustainable practices. We are pleased to be supporting Vulcan in meeting Europe’s needs for the electric vehicle transition, from a zero-carbon source, for many years to come. Together, we will set a new benchmark for the responsible sourcing of raw materials to enable sustainable mobility for the future.”

More reading

• Why Corporate Travel Management, Silver Lake, Volpara, & Vulcan are pushing higher
• Why the Vulcan Energy (ASX:VUL) share price is charging higher today
• Why the Vulcan Energy (ASX:VUL) share price is up today
• Mining companies with ESG strategies are at the front of the pack
• Vulcan Energy (ASX: VUL) share price up as revenue soars over 1,000%

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Vulcan Energy (ASX:VUL) share price is charging 9% higher appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3cbKA85

The Sigma Healthcare Ltd (ASX: SIG) share price is pushing higher on Tuesday following the release of its full year results.

In morning trade, the pharmacy chain operator and distributor’s shares are up almost 7% to 71.5 cents.

How did Sigma perform in FY 2020?

For the 12 months ended 31 January, Sigma reported a 4.8% increase in revenue to $3.4 billion. This was driven by a combination of organic growth from its core wholesale sales and pharmacy brands, along with new business.

In respect to the latter, the company notes that sales to Chemist Warehouse reached their full annualised run rate by June 2020 and remain on track to achieve $800 million in sales over a 12-month period.

Sigma’s earnings grew at a quicker rate on both a reported and underlying basis. This was thanks partly to Project Pivot. This transformation program has now concluded, having delivered on the target of $100+ million in efficiency gains.

Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) rose 39.2% to $81.1 million. This was slightly ahead of its guidance for the year. And on the bottom line, the company’s underlying net profit after tax jumped 133.6% to $29.1 million.

In light of its return to form, the Sigma board has reinstated its dividend and declared a fully franked 1 cent per share final dividend.

“Milestone result”

Sigma’s CEO and Managing Director, Mark Hooper, was very pleased with the result, particularly given the COVID-19 pandemic.

He commented: “This is a milestone result. We’ve delivered on our promise of transforming our business and improving our earnings as we enter a period of sustainable growth and improved returns for shareholders.”

“Significantly, Sigma has navigated the challenges of the COVID-19 pandemic without any reliance on direct government support such as Job Keeper. We have the building blocks in place to underpin our target of 10% per annum growth in Underlying EBITDA for the next two years and around $100m by FY23,” he added.

Outlook

The company’s Chairman, Ray Gunston, believes shareholders should be confident about Sigma’s future growth prospects.

He said: “We have taken significant strides to transform our business, upgrade our infrastructure, improve our operating performance, and enhance our culture. At the same time, we have reduced net debt to $50m at year end. Collectively, it means we are now in an improved position to execute our strategy and actively pursue opportunities for sustainable growth including in our expansion businesses.”

This sentiment was echoed by its CEO. Mr Cooper concluded: “Following a period of significant change, Sigma is now a stronger business and on track to delivering our targeted 10% annual organic growth over the next two years. Having targeted $100m Underlying EBITDA by FY23, we now approach that milestone with far greater confidence. We also sharpen our focus on business development to accelerate our expansion businesses, including in the medical consumables and devices space.”

More reading

• Respiri (ASX:RSH) share price on watch following FDA approval
• Why the New Hope (ASX:NHC) share price is in focus
• Kathmandu (ASX:KMD) share price on watch as dividends resume
• Is the Telstra (ASX:TLS) share price a buy after its restructure update?
• Why the Oceania (ASX:OCA) share price is frozen

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Sigma (ASX:SIG) share price up 7% after doubling full year profits appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3lHzzOU

The Respiri Ltd (ASX: RSH) share price is on watch today after the company advised it has received United States Food and Drug Administration (FDA) clearance for its Wheezo app. 

About Respiri  

Respiri is a software-as-a-service (SaaS) company supporting asthma patients to monitor and manage their asthma. The company views that asthma is often under-diagnosed and under-treated, creating a substantial burden to sufferers and their families. 

Respiri has created an eHealth SaaS platform, ‘Wheezo’, that uses a device and app to measure, record and monitor asthma symptoms. The device records breath sounds over 30 seconds to be analysed in the app. The app has features that allow users to log symptoms, triggers, medication and local environment factors, which can then be used to build a personalised asthma profile to be shared with healthcare professionals. 

The company believes the sub-optimally managed asthma market represents a significant opportunity, with over 340 million people affected globally. 

Respiri share price in focus 

The Respiri share price will be on the radar this morning after the company announced it has received clearance from the US FDA for Wheezo, thus permitting the company to market and sell its product in the US as a class II medical device alongside the Wheezo app. 

Respiri CEO and Managing Director Mr Marjan Mikel commented on clearance: 

The regulatory clearance of Wheezo and our App in the United States represents a highly significant and major milestone for the Company as we continue to expand our regulatory footprint for Wheezo and enter substantial new markets. The FDA is one of the most stringent regulatory bodies in the world and this clearance further validates the efficacy and utility of our Wheezo device and algorithm. To our knowledge [this is] the first time the FDA has cleared a device/mobile application for the detection, recording and changes of wheeze rates. This represents a step-change in technology for patients with respiratory wheeze seeking an effective, replicable and rapid device measurement and associated App that monitors this important measurement of lung function.

Respiri plans to launch in the US market in Q3 2022 with an initial focus on the 60% of children with persistent and severe asthma, representing 3.3 million patients. According to the company, the Wheezo device and app will play a role in providing significant analytical information for patients and their caregivers. 

Respiri highlights the reimbursement codes available from the Centers for Medicare and Medicaid Services (CMS) in the US as a key tailwind for Wheezo. These enable clinicians and qualified medical professionals advising patients on the purchase of the device and associated SaaS fees to receive financial compensation for the time spent and equipment used for patient care delivered remotely. 

More reading

• Why the New Hope (ASX:NHC) share price is in focus
• Kathmandu (ASX:KMD) share price on watch as dividends resume
• Is the Telstra (ASX:TLS) share price a buy after its restructure update?
• Why the Oceania (ASX:OCA) share price is frozen
• ASX 200 crash anniversary: 5 of the best performing shares of the last 12 months

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Respiri (ASX:RSH) share price on watch following FDA approval appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3c9f5LR

The New Hope Corporation Ltd (ASX: NHC) share price is one to watch after the coal miner’s half-year results announcement.

Why is the New Hope share price on watch?

Today, New Hope reported its half-year results for the period ended 31 January 2021 (1H 2021). The Aussie miner reported what it called a “solid performance” despite a “depressed energy market”.

Both pricing and volumes fell during the quarter and weighed on revenue and earnings. Total tonnes sold fell 23% from 2020 to 4.9 million while the realised sales price of $78.8 per tonne was down 19% on 2020 figures.

Revenue from operations consequently slumped 34% to $405.5 million. Earnings before interest, tax, depreciation and amortisation (EBITDA) before non-regular items fell 62% to $81.2 million.

The New Hope share price is worth watching given the significant profitability hit during the period. That includes a 99% drop in profit before income tax (before non-regular items) to $0.9 million.

Shareholders will also be watching the interim dividend announcement from today’s results. New Hope slashed its interim dividend by 33% to 4.0 cents per share as a result of reduced profits.

The coronavirus pandemic has crimped demand for energy around the world and hit commodity prices hard. That lack of demand saw New Hope’s EBITDA margin fall 41% from 2020 to 20% in 1H 2021.

Higher NSW and Queensland costs during the second quarter weighed on that EBITDA result. Bengalla coal production fell 16.3% from 2020 to 4.6 megatonnes while Queensland operations produced 0.9 megatonnes, down 43.8% from 2020.

Cash generated from operations slumped 58% to $70.2 million for the period. Profit after tax and non-regular items fell 179% as New Hope posted a $55.4 million net loss. On the balance sheet side, New Hope’s gearing ratio came in at 14% and the company remains in compliance with all debt covenants.

New Hope is forecasting “continued strong performance” at Bengalla with targeted cost reductions across the business. The miner said coal prices are expected to stabilise in the short and long term with good demand from Asian markets.

Foolish takeaway

The New Hope share price is one to watch in early trade after this morning’s half-year report. Revenue and earnings slumped for the year due to a depressed energy market despite Bengalla sales coming in better than expected for the period.

New Hope slashed its interim dividend by 33% to 4.0 cents per share as a result of lower profit and a focus on capital management.

More reading

• 3 reasons why Brickworks is a great ASX dividend share
• No ASX dividend share is perfect, but Soul Patts (ASX:SOL) is more perfect than most

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the New Hope (ASX:NHC) share price is in focus appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2PmPPsU

Kathmandu Holdings Ltd (ASX: KMD) shares are on watch today after the company released its half-year results and reported its dividend has resumed. The Kathmandu share price closed Monday’s session 1.3% lower at $1.14.

Let’s look closer at Kathmandu’s announcements today.

Kathmandu’s half-year results

The Kathmandu share price will be in focus this morning after the company announced it will pay shareholders a dividend for the first time since October 2019. Although, the NZ 2 cent (AUD 1.9 cent) per share fully franked dividend is the company’s smallest yet.

Kathmandu boasted that its half-year sales were up by 12.9% to around $410 million. Its underlying earnings before interest, tax, depreciation and amortisation (EBITDA) was also up by 19%, standing at around $48 million. 

The company’s half-year results show that its 2019 acquisition of Rip Curl may have been a stroke of genius, as the brand held the company’s EBITDA strong through the first half of the 2021 financial year. Particularly as international border closures reduced consumer demand for Kathmandu’s insulation and rainwear.

Kathmandu stated Rip Curl’s wholesale forward orders are now above pre-COVID levels.

The half-year results also mentioned Kathmandu-owned brand Oboz is seeing sales growth and has a strong forward order book.

Commentary from management

Kathmandu group’s CEO Xavier Simonet said Rip Curl’s outstanding first-half result has validated Kathmandu’s diversification strategy.

Benefiting from increased participation in surfing in Australia, Europe and the USA, Rip Curl achieved strong sales and profits despite COVID-19 trading restrictions, reflecting the brand’s technical product focus and strong consumer engagement.

Over the first half, we implemented a rapid response to changes in consumer preference resulting from COVID-19. To respond to increased participation in local travel and adventure, our brands adjusted their focus to product categories in high demand, such as wetsuits and surfboards for Rip Curl, and camping and footwear for Kathmandu. Omni-channel capability allowed our brands to capture record demand for the online channel, with online penetration now making up almost 13% of the Group’s direct to consumer sales.

Kathmandu share price snapshot

The Kathmandu share price has spent the last 12 months recovering from a steep drop in March 2020 due to COVID-19. It is currently 141.49% higher than it was this time last year. Although, it is still 49.1% lower than it was on the first trading day of 2020. Year to date, Kathmandu shares are down by 3.81%.

The company has a market capitalisation of around $804 million, with 709 million shares outstanding.

More reading

• ASX quarterly rebalance: HUB24 joins ASX 200, Brainchip into ASX 300

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Kathmandu (ASX:KMD) share price on watch as dividends resume appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3fbuP3b

On Monday the Telstra Corporation Ltd (ASX: TLS) share price pushed higher following an update on its proposed legal restructure. You can read about that here and also here.

This led to the Telstra share price climbing almost 1.5% to $3.25.

Is the restructure a good idea?

According to analysts at Goldman Sachs, they believe the restructure is a big positive and expect it to unlock value for shareholders.

In light of this, this morning the broker has retained its buy rating and $4.00 price target on the telco giant’s shares.

Based on the current Telstra share price, this price target implies potential upside of 23% for its shares over the next 12 months.

And with Goldman Sachs forecasting fully franked dividends of 16 cents per share for the foreseeable future, the 12-month total potential return on offer here stretches to approximately 28% if you include dividends.

What did Goldman Sachs say?

Goldman is pleased with its plans and believes the company’s shares are undervalued at the current level.

It said: “We remain positive on TLS, as this update outlines the next steps of the corporate restructure and potential asset monetization, and gives us confidence that its infrastructure value will ultimately be realized by shareholders. Based on our updated transaction multiples/illustrative SOTP valuations, TLS shares currently trade on just 4.1-4.7x ServeCo FY23E EBITDA or 5.7-6.3X at our unchanged A$4.00 12m TP, vs. SPK.NZ at 8.3x. We reiterate our Buy on TLS, our preferred ANZ Telco, ahead of its FY21 results and Nov-21 ID, both of which we view as positive catalysts.”

What are the downside risks for the Telstra share price?

While Goldman is positive on the company, it has named a few risks for the Telstra share price that investors ought to consider before investing.

It explained: “Downside risks for TLS include: 1) Increased competition, particularly in the mobile market, 2) disappointing cost out relative to its $2.7bn productivity program, 3) unfavourable regulation across its businesses; 4) asset monetisation is ultimately unsuccessful.”

Though, based on its rating and price target, the risks appear skewed to the upside at present.

More reading

• Top brokers name 3 ASX dividend shares to buy today
• Why the Spacetalk (ASX:SPA) share price has exploded 40% in a week
• Why the Telstra (ASX:TLS) share price is on the move today
• ASX 200 Weekly Wrap: Inflation fears hold ASX down
• 2 high yield ASX dividend shares to buy

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Is the Telstra (ASX:TLS) share price a buy after its restructure update? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3sddV7T

The Oceania Healthcare Ltd (ASX: OCA) share price won’t be going anywhere today after the company’s shares were placed in a trading halt. This comes after Oceania unveiled plans for its latest capital raise.

Why is the Oceania share price in a trading halt?

Oceania today announced plans to raise ~NZ$100 million to fund its latest acquisition plans. The company will seek to raise NZ$80 million via a fully underwritten placement and a NZ$20 million non-underwritten retail offer. Oceaniea will have the ability to accept oversubscriptions at its discretion.

The funds will be used in the acquisition of a premium retirement village, Waterford on Hobsonville Point, in Auckland, New Zealand. Oceania is also planning to use the money in its existing leased facility and adjacent development land in Franklin.

The Oceania share price will be one to watch when the company’s shares return to trade early next week.

Oceania said in today’s release that the funds will provide additional financial capacity for its future growth and reduce corporate debt outstanding while other growth opportunities are assessed.

The Kiwi healthcare group’s shares will enter a trading halt today with plans to re-commence trading on Monday 29 March.

Oceania’s placement will be fully underwritten by Jarden Partners Limited and Macquarie Securities (NZ) Limited. The placement is underwritten at a fixed price of NZ$1.30 per share – a 6.5% discount to the last close price of NZ$1.39 per share on 22 March.

The Waterford on Hobsonville Point site comprises 64 independent living villas and 36 independent living apartments. Oceania’s acquisition is expected to settle in April or May 2021 and remains conditional on relevant approvals.

What else has been happening for Oceania?

The Oceania share price climbed higher on Monday after the company announced its new CEO. Former CFO, Brent Sutton, has been appointed the group’s new CEO effective immediately.

The news saw the Kiwi healthcare share edge higher yesterday after former CEO Earl Gasparich was poached by Metlifecare Limited earlier this month.

More reading

• Oceania (ASX:OCA) share price rises on new CEO announcement

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Oceania (ASX:OCA) share price is frozen appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2PiMyKO

Today is a momentous day. This time last year, on 23 March 2020, the S&P/ASX 200 Index (ASX: XJO) was having one of its worst days yet with the coronavirus-induced market crash. The market was plummeting after yet another night of heavy selling over in the United States.

Little did we know at the time, though, that this would be the day the ASX 200 found its bottom. Yes, after 23 March, it was only onwards and upwards. More so for some shares than others, of course.

Here are 5 of the best performing ASX shares since that fateful day (in ascending order of performance):

5 of the best performing ASX shares since the COVID crash

5. Zip Co Ltd (ASX: Z1P)

At today’s share price of $8.21, it’s hard to imagine Zip Co at just $1.05 a share. Yet that’s where this buy now, pay later (BNPL) company briefly found itself 12 months ago. But fast forward one year and Zip shareholders have a 682% gain under their belts. Not a bad outcome at all.

4. Pilbara Minerals Ltd (ASX: PLS)

Pilbara was hit by a perfect storm this time last year. Lithium miners like Pilbara had been in a bear market long before COVID-19 graced our lives. So when the market crashed, Pilbara was pushed to multi-year lows, bottoming out at 13 cents a share on 23 March 2020.

Today, Pilbara is a $1.02 stock, meaning investors have enjoyed a 685% recovery.

3. Afterpay Ltd (ASX: APT)

Afterpay has become a poster child of the ASX 200 recovery. It famously got down to a price of $8.01 on March 23 last year, down from the near-$20 a share it was commanding a month earlier.

Remember, that seemed ludicrously expensive at the time for the BNPL pioneer! But today, Afterpay is going for $109.53 a share – a move I’m not sure even the bulls of the bulls could have dreamed of a year ago. That’s a return of 1,267%, thank you very much!

2. Pointsbet Holdings Ltd (ASX: PBH)

Pointsbet shareholders were wiped out by around 80% between 14 February and 23 March last year. But anyone who had the nerves of steel to hold on has been richly rewarded for their courage.

Since reaching a low of $1.04 on 23 March last year, Pointsbet closed yesterday at a price of $14.24 a share. That’s a handy 1,269% return.

1. Redbubble Ltd (ASX: RBL)

Last, but certainly not least is Redbubble, a company known for helping artists sell their works on various innovative mediums (like mugs for instance) online. Last March seemed to coincide with a slump Redbubble had been working through over the previous months.

It reached a low of 40 cents on 23 March. But today, Redbubble shares are worth, at the time of writing, $5.70 each. That’s a return of… drumroll…. a whopping 1,325%. Just for some context, that return would result in a $10,000 investment then being worth $132,500 today.

Foolish takeaway

Got FOMO yet? I know I have, so that’s all for today! But this does go to show that selling your favourite companies in the worst throes of a market crash might just be one of the worst financial decisions you can ever make.

More reading

• Time to be bullish or bearish on the Afterpay (ASX:APT) share price?
• 5 things to watch on the ASX 200 on Tuesday
• ASX 200 climbs, Crown soars, Mineral Resources drops
• Top broker issues buy alert on Santos (ASX:STO) and these ASX energy shares
• ASX 200 up 0.35%: Crowns surges, ANZ & CBA settle class actions

Sebastian Bowen (unfortunately) has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Pointsbet Holdings Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post ASX 200 crash anniversary: 5 of the best performing shares of the last 12 months appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/31aJByR

The Pushpay Holdings Ltd (ASX: PPH) share price will be one to watch this morning following the release of an announcement relating to a new cornerstone investor.

In early trade in New Zealand, the donation and engagement platform provider’s NZX-listed shares are trading 5% higher.

What did Pushpay announce?

This morning Pushpay revealed that the Huljich family has finally completed the selldown of its holding in the company.

According to the release, Christopher & Banks V Limited, the investment vehicle associated with Peter Huljich and Christopher Huljich, have sold 100% of their remaining shares in Pushpay to leading global investment firm Sixth Street.

In doing so, Pushpay understands that Sixth Street will become its largest shareholder, holding approximately 17.8% of its shares outstanding after the acquisition completes on 30 March 2021.

What is Sixth Street?

The release explains that Sixth Street is a global investment firm with over US$50 billion in assets under management and committed capital.

It was founded in 2009 and has more than 320 team members, including over 145 investment professionals operating from nine locations around the world.

Sixth Street has a long-term oriented and highly flexible capital base, allowing it to invest thematically across sectors, geographies, and asset classes.

Select current and past investments in growth companies include Airbnb, AirTrunk, AvidXchange, Gainsight, Kyriba, MDLIVE, Paycor, PaySimple, Spotify, and SumUp.

“Delighted”

Pushpay’s Chairman, Graham Shaw, was delighted to have Sixth Street on board.

He said: “We are delighted to welcome Sixth Street as a cornerstone investor in Pushpay. As a highly experienced technology and growth investor with a core thematic focus on the convergence of software and payments, Sixth Street’s global scale and partnership-oriented investing approach brings considerable strength to Pushpay’s shareholder register.”

“On behalf of Pushpay, I would also like to sincerely thank Peter and Christopher Huljich for their invaluable contribution and commitment to the business over the past seven years. We are extremely grateful for their support and wish them all the best with their future endeavours.”

More reading

• 3 of the best ASX shares to buy this month
• 2 ASX shares that are rapidly growing
• 10 of the best ASX shares to buy in March
• 2 fantastic ASX shares with long runways for growth
• 4 top reasons why the Pushpay (ASX:PPH) share price could be a buy

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia has recommended PUSHPAY FPO NZX. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Here’s why the Pushpay (ASX:PPH) share price could surge higher today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2Qvod5j

Fortunately, in this low interest rate environment, there are countless dividend shares for investors to choose from on the Australian share market.

But with so many to choose from, it can be hard to decide which ones to buy. To narrow things down, I have picked out three ASX dividend shares that brokers think investors should buy:

Metcash Limited (ASX: MTS)

According to a note out of Goldman Sachs, its analysts have retained their buy rating and lifted their price target on this wholesale distributor’s shares to $4.03. Goldman was pleased with Metcash’s latest strategy update, which highlighted a shift in its strategy to a growth footing. In addition to this, it notes that management has flagged its strong capital position by increasing its dividend payout ratio. In light of the latter, Goldman is now forecasting fully franked dividends of 19 cents per share in FY 2021 and 18 cents per share in FY 2022. Based on the current Metcash share price of $3.49, this will mean yields of 5.4% and 5.15%, over the next couple of years.

Telstra Corporation Ltd (ASX: TLS)

Analysts at Ord Minnett have recently upgraded this telco giant’s shares to a buy rating with a $4.05 price target. According to the note, the broker believes Telstra is well-placed to benefit from the 5G rollout due to its superior network. In addition to this, it believes its shares are good value and offer an attractive yield. Ord Minnett expects Telstra to continue paying a 16 cents per share dividend over the next couple of years. Based on the current Telstra share price of $3.25, this will equate to a fully franked 4.9% dividend yield.

Westpac Banking Corp (ASX: WBC)

A note out of Citi reveals that its analysts have retained their buy rating and $26.00 price target on this banking giant’s shares. According to the note, the broker believes there is scope for the banking sector to continue to outperform as more investors rotate into bank shares due to rising bond yields and their improving outlooks. Citi is expecting Westpac to pay $1.30 per share fully franked dividends over the next couple of years. Based on the Westpac share price of $24.66, this will mean a generous 5.3% yield.

More reading

• Why the Spacetalk (ASX:SPA) share price has exploded 40% in a week
• These are the 10 most shorted shares on the ASX
• Why the Telstra (ASX:TLS) share price is on the move today
• Why the Commonwealth Bank (ASX: CBA) share price is on watch today
• ASX 200 Weekly Wrap: Inflation fears hold ASX down

Motley Fool contributor James Mickleboro owns shares of Westpac Banking. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Top brokers name 3 ASX dividend shares to buy today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3f8Vuxk